• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植后淋巴组织增生性疾病中里德-施特恩伯格样细胞的EB病毒潜伏膜蛋白(LMP-1)和bcl-2蛋白表达

EBV latent membrane protein (LMP-1) and bcl-2 protein expression in Reed-Sternberg-like cells in post-transplant lymphoproliferative disorders.

作者信息

Chetty R, Biddolph S C, Kaklamanis L, Cary N, Stewart S, Giatromanolaki A, Gatter K C

机构信息

University Department of Cellular Science, University of Oxford, Cambridge, UK.

出版信息

Histopathology. 1996 Mar;28(3):257-60. doi: 10.1046/j.1365-2559.1996.d01-425.x.

DOI:10.1046/j.1365-2559.1996.d01-425.x
PMID:8729046
Abstract

An inconsistent association exists between EBV-LMP-1 and bcl-2 protein expression in Reed-Sternberg cells seen in Hodgkin's disease. In fact, many studies have concluded that there is no correlation between EBV-LMP and bcl-2 expression in Hodgkin's disease. We undertook an analysis of post-transplant lymphoproliferative disorders to explore the relationship between EBV-LMP and bcl-2 in Reed-Sternberg-like cells found in this condition, given the strong association between this disorder and EBV. Reed-Sternberg-like cells were found histologically in 11 of 28 cases of renal, heart and heart-lung post-transplant lymphoproliferative disorders. Formalin-fixed, paraffinembedded sections were stained with monoclonal antibodies to EBV-LMP-1 and bcl-2 proteins. Reed-Sternberg-like cells in all 11 cases co-expressed EBV-LMP and bcl-2. A similar relationship was noted with large, mononuclear cells and occasional small lymphoid cells. The staining pattern seen with both antibodies was of similar intensity and both displayed cytoplasmic Golgi accentuation. In the setting of post-transplant lymphoproliferative disorders. Reed-Sternberg-like cells exhibit strong co-expression of EBV-LMP-1 and bcl-2 proteins, supporting a positive correlation between them. This is in contrast to the findings in Hodgkin's disease. The reason for this discrepancy may be due to the iatrogenic immunosuppression and resultant severe EBV infection, together with other cellular events.

摘要

在霍奇金病中所见的里德-斯腾伯格细胞中,EBV-LMP-1与bcl-2蛋白表达之间存在不一致的关联。事实上,许多研究得出结论,霍奇金病中EBV-LMP与bcl-2表达之间没有相关性。鉴于移植后淋巴细胞增生性疾病与EBV之间存在密切关联,我们对其进行了分析,以探讨在此疾病中发现的里德-斯腾伯格样细胞中EBV-LMP与bcl-2之间的关系。在28例肾、心脏和心肺移植后淋巴细胞增生性疾病中,有11例在组织学上发现了里德-斯腾伯格样细胞。用抗EBV-LMP-1和bcl-2蛋白的单克隆抗体对福尔马林固定、石蜡包埋的切片进行染色。所有11例中的里德-斯腾伯格样细胞均共表达EBV-LMP和bcl-2。在大的单核细胞和偶尔的小淋巴细胞中也观察到类似的关系。两种抗体的染色模式强度相似,且均显示胞质高尔基体增强。在移植后淋巴细胞增生性疾病的情况下,里德-斯腾伯格样细胞表现出EBV-LMP-1和bcl-2蛋白的强共表达,支持它们之间存在正相关。这与霍奇金病的研究结果形成对比。这种差异的原因可能是医源性免疫抑制以及由此导致的严重EBV感染,以及其他细胞事件。

相似文献

1
EBV latent membrane protein (LMP-1) and bcl-2 protein expression in Reed-Sternberg-like cells in post-transplant lymphoproliferative disorders.移植后淋巴组织增生性疾病中里德-施特恩伯格样细胞的EB病毒潜伏膜蛋白(LMP-1)和bcl-2蛋白表达
Histopathology. 1996 Mar;28(3):257-60. doi: 10.1046/j.1365-2559.1996.d01-425.x.
2
An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin's disease and Reed-Sternberg-like cells in non-Hodgkin's lymphomas and reactive conditions.移植后淋巴细胞增生性疾病中里德-施特恩伯格样细胞的免疫组织化学分析:与霍奇金病中的里德-施特恩伯格细胞、非霍奇金淋巴瘤及反应性病变中的里德-施特恩伯格样细胞可能的致病关系
Hum Pathol. 1997 Apr;28(4):493-8. doi: 10.1016/s0046-8177(97)90040-x.
3
bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders.bcl-2蛋白在移植后淋巴细胞增殖性疾病中强烈表达。
J Pathol. 1996 Nov;180(3):254-8. doi: 10.1002/(SICI)1096-9896(199611)180:3<254::AID-PATH671>3.0.CO;2-D.
4
Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.里德-施特恩伯格细胞中c-myc和bcl-2癌基因产物的表达与爱泼斯坦-巴尔病毒的存在无关。
J Clin Pathol. 1993 Mar;46(3):211-7. doi: 10.1136/jcp.46.3.211.
5
Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.在无明显既往免疫缺陷的患者中发生的霍奇金淋巴瘤和非霍奇金淋巴瘤中,爱泼斯坦-巴尔病毒潜伏基因产物以及相关细胞活化和黏附分子的表达
Hum Pathol. 1993 Jul;24(7):725-9. doi: 10.1016/0046-8177(93)90008-5.
6
The expression of the EBV latent membrane protein (LMP-1) is independent of CD23 and bcl-2 in Reed-Sternberg cells in Hodgkin's disease.在霍奇金病的里德-斯腾伯格细胞中,EB病毒潜伏膜蛋白(LMP-1)的表达独立于CD23和bcl-2。
Histopathology. 1992 Jul;21(1):72-3. doi: 10.1111/j.1365-2559.1992.tb00346.x.
7
Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.bcl-2蛋白和爱泼斯坦-巴尔病毒潜伏膜蛋白在霍奇金淋巴瘤中的表达
Pol J Pathol. 1994;45(4):279-81.
8
Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.bcl-2蛋白表达及爱泼斯坦-巴尔病毒bcl-2同源物BHRF-1在霍奇金病中的转录:对不同致病机制的意义
Histopathology. 1995 Jun;26(6):547-53. doi: 10.1111/j.1365-2559.1995.tb00273.x.
9
Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.霍奇金病的里德-斯腾伯格细胞及其变异型中爱泼斯坦-巴尔病毒编码的潜伏膜蛋白的免疫组织化学检测
Mod Pathol. 1994 May;7(4):454-61.
10
Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?爱泼斯坦-巴尔病毒感染与bcl-2原癌基因表达。霍奇金淋巴瘤发病机制中的独立事件?
Am J Pathol. 1993 Nov;143(5):1270-4.

引用本文的文献

1
Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders.在诊断时出现淋巴细胞减少症可预测免疫缺陷相关淋巴增生性疾病患者的生存情况。
Ann Hematol. 2020 Jul;99(7):1565-1573. doi: 10.1007/s00277-020-04084-5. Epub 2020 May 20.
2
Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.移植后淋巴组织增生性疾病及艾滋病相关淋巴瘤单细胞水平上EB病毒Ⅲ型潜伏感染的存在情况
J Clin Pathol. 1997 Nov;50(11):911-8. doi: 10.1136/jcp.50.11.911.